Veralox Therapeutics
United States · $46.0M raised
- Business Model
- B2B
- Website
- veralox.com
- Total Funding
- $46.0M
- Last Round
- $5.4M SeedJun 2023
- Rounds
- 3
About
Clinical-stage biotech developing first-in-class small molecule therapeutics targeting 12-Lipoxygenase and cGAS pathways.
Summary
Veralox Therapeutics is a Biotech company based in United States. It has raised $46.0M in total across 3 rounds, most recently a $5.4M Seed round in Jun 2023. Investors include JDRF T1D Fund, Sanofi Ventures and Pappas Capital.
Tech & App Stack
7 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...